Procter Gamble Health Ltd vs Sandu Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 16, 2026

Key Highlights

The Latest Trading Price of Procter & Gamble Health Ltd is ₹ 5286 as of 15 May 15:30 . The P/E Ratio of Procter & Gamble Health Ltd is 0 as of March 2023 .The P/E Ratio of Sandu Pharmaceuticals Ltd is 33.3 as of March 2023 . The Market Cap of Procter & Gamble Health Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Sandu Pharmaceuticals Ltd is ₹ 50.43 crore as of March 2023 . The revenue of Procter & Gamble Health Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sandu Pharmaceuticals Ltd for the Mar '25 is ₹ 14.14 crore as compare to the Dec '24 revenue of ₹ 18.4 crore. This represent the decline of -23.15% The ebitda of Procter & Gamble Health Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sandu Pharmaceuticals Ltd for the Mar '25 is ₹ 0.52 crore as compare to the Dec '24 ebitda of ₹ 1.02 crore. This represent the decline of -49.02% The net profit of Procter & Gamble Health Ltd changed from ₹ 0 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of 0.0% The net profit of Sandu Pharmaceuticals Ltd changed from ₹ 0.17 crore to ₹ 0.33 crore over 4 quarters. This represents a CAGR of 94.12% The dividend payout of Procter & Gamble Health Ltd changed from 122.06 % to 0 % over 9 quarters. This represents a CAGR of -100.00% The dividend payout of Sandu Pharmaceuticals Ltd changed from 49.86 % to 52.93 % over 5 quarters. This represents a CAGR of 4.90% .

About Procter & Gamble Health Ltd

Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967.
The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002.
Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019.
The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and liabilities.
The company is a 51% subsidiary of German firm Merck KGaA, is a leading player in vitamin formulations. Procter & Gamble Health Limited is an Indian-based company principally engaged in the business of manufacturing and marketing of pharmaceuticals and chemicals.

About Sandu Pharmaceuticals Ltd

Sandu Pharmaceuticals Limited (SPL) was established in 1987.
The Company is mainly engaged in the business of manufacturing and trading of Ayurvedic medicines under the brand name 'SANDU' and is having a plant unit in Goa. SPL came out with a public issue of 17.70 lac equity shares at par, aggregating Rs 1.77 cr, in Sep.'94, to part-finance its new project in Goa costing Rs 7.28 cr to manufacture ayurvedic medicines and formulations.
This plant employs the latest material handling systems and other modern machinery and has the most hygienic production facilities to attain the highest possible quality standards.
Ayurvedic products have a very good market in India and abroad due to their minimal side effects. The company commenced commercial production of Ayurvedic Medicines & Formulations, at the Goa plant in 1996-97.

FAQs for the comparison of Procter & Gamble Health Ltd and Sandu Pharmaceuticals Ltd

Which company has a larger market capitalization, Procter & Gamble Health Ltd or Sandu Pharmaceuticals Ltd?

Market cap of Procter & Gamble Health Ltd is 8,775 Cr while Market cap of Sandu Pharmaceuticals Ltd is 37 Cr

What are the key factors driving the stock performance of Procter & Gamble Health Ltd and Sandu Pharmaceuticals Ltd?

The stock performance of Procter & Gamble Health Ltd and Sandu Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Procter & Gamble Health Ltd and Sandu Pharmaceuticals Ltd?

As of May 16, 2026, the Procter & Gamble Health Ltd stock price is INR ₹5286.55. On the other hand, Sandu Pharmaceuticals Ltd stock price is INR ₹38.39.

How do dividend payouts of Procter & Gamble Health Ltd and Sandu Pharmaceuticals Ltd compare?

To compare the dividend payouts of Procter & Gamble Health Ltd and Sandu Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.